Improvement in neurological signs and symptoms of thalamic syndrome (Dejerine-Roussy Syndrome) due to a stroke 20 years previously (in 1998) after treatment at the Institute of Neurological Recovery in Boca Raton in September 2018, by Edward Tobinick, M.D. Text, images and video © 2018, INR PLLC, all rights reserved.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Perispinal etanercept is a method of targeting detrimental neuroinflammation using etanercept, a special anti-inflammatory drug, delivered utilizing a novel, non-invasive injection method.
Perispinal etanercept is NOT experimental. Perispinal etanercept has been used to treat more than 5,000 chronic stroke patients since 2010 at the Institute of Neurological Recovery.
No, it is not too late. Neuroinflammation can last for years, or even decades, after brain injury. Life-changing neurological improvements following perispinal etanercept treatment performed weeks, months, years, or even decades after stroke or brain injury are not uncommon.
Referrals are not required. The Institute of Neurological Recovery has received, and welcomes, referrals from neurologists, speech pathologists, physical therapists, occupational therapists, primary care physicians, online stroke groups, and, of course, patients and their family members.
Receive detailed information regarding the Institute’s unique, patented, anti-inflammatory treatment. We currently treat and accept new patients from around the world, even years or decades after stroke or traumatic brain injury.
Complete the form and a member of our team will be in touch shortly.
